InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
63,661.36
(
-0.91%
)
Post# of 42458
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oldberkeley

Send PM Follow Ignore
Followers 58
Posts 5142
Boards Moderated 0
Alias Born 07/23/2007

oldberkeley

Re: None

Friday, 04/12/2013 10:31:22 AM

Friday, April 12, 2013 10:31:22 AM

Post# of 42458
Only for hardcore biotech fans: XNPT drop today is way overdone, GSK makes Horizant for them and has a production delay. Thing is, Horizant is not going to be XNPT's real value driver, it's two other drugs in their pipeline. (It's a long, complicated story!)

Big Phase III results coming up in May, expert predictions are very bullish. I've been accumulating anywhere around $7, $8.50-$9 target.

All that is needed to make a happy life is within yourself, in your way of thinking. -Marcus Aurelius

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up